Home NDC 70377-116 Liothyronine sodium
Product NDC 70377-116
11-digit product format 703770116
Labeler code 70377
Product ID 70377-116_c2af2408-91ba-b0c3-349f-20ca285e0fc9
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Liothyronine sodium
Dosage form TABLET
Route ORAL
Labeler Biocon Pharma Inc.
Application ANDA218070
Marketing category ANDA
Marketing start 2024-02-12
Substance LIOTHYRONINE SODIUM
Active strength 50 ug/1
Pharmacologic classes Triiodothyronine [CS], l-Triiodothyronine [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A218070-001 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 A218070-002 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 A218070-003 LIOTHYRONINE SODIUM LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 51 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A218070-002 LIOTHYRONINE SODIUM EQ 0.025MG BASE TABLET / ORAL AB 2024-02-06 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A218070-003 LIOTHYRONINE SODIUM EQ 0.05MG BASE TABLET / ORAL AB 2024-02-06 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A218070-001 LIOTHYRONINE SODIUM EQ 0.005MG BASE TABLET / ORAL AB 2024-02-06 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 51 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Liothyronine sodium
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LIOTHYRONINE SODIUM 50 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination GCA9VV7D2N Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 903456 Internal RxNorm lookup 903697 Internal RxNorm lookup 903703 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70377-116-11 Liothyronine sodium 90 in 1 BOTTLE TABLET 90 4 70377-116-12 Liothyronine sodium 100 in 1 BOTTLE TABLET 100 4 70377-116-13 Liothyronine sodium 1000 in 1 BOTTLE TABLET 1000 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70377-116 LIOTHYRONINE SODIUM TABLET [BIOCON PHARMA INC.] 4 Current NDC, 3 package rows 20240405_21002702-422b-1402-73b8-670314d8e579.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70377-116-11 70377011611 90 TABLET in 1 BOTTLE (70377-116-11) 90 tablet 2024-02-12 No No Current 70377-116-12 70377011612 100 TABLET in 1 BOTTLE (70377-116-12) 100 tablet 2024-02-12 No No Current 70377-116-13 70377011613 1000 TABLET in 1 BOTTLE (70377-116-13) 1000 tablet 2024-02-12 No No Current